IntelliNetx

IntelliNetx is an AI-driven biotechnology company dedicated to transforming drug discovery through the use of "Intelligent Networks." Founded by Dr. Thomas Chittenden, the company employs advanced machine learning and causal inference to map the complex functional architecture of human disease. Their proprietary platform integrates multi-omic data to identify novel therapeutic targets and high-confidence biomarkers, with a primary focus on oncology and neurodegenerative disorders. By decoding the causal mechanisms of disease, IntelliNetx aims to develop precision medicines that offer higher clinical success rates than traditional discovery methods. The company is currently in the pre-clinical stage, leveraging its computational platform to build a robust pipeline of internal and partnered programs.